I guess we'll see at the end of July whether costs have reverted to those of earlier quarters (after the March '22 quarter included a couple of milestone payments adding circa $6m to outgoings) or not. If they have, this buys us until end of calendar year or early 2023 - by my rudimentary estimations - before a cash injection of some sort is required. I think we are all hoping that an MPS deal or regional OA deal might come about during that time. Fingers crossed. If not, and a CR is required, it'll get choppy.
Just an aside, but R&D rebate coming next year for spend during FY22 should be hefty.
Look forward eagerly to the next update on dataroom interest.
I guess we'll see at the end of July whether costs have reverted...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $85.35K | 365.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 280011 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 44703 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |